Joel A Sincavage
Supervisory Patent Examiner (ID: 11124, Phone: (571)272-2610 , Office: P/2910 )
Most Active Art Unit | 2911 |
Art Unit(s) | 2911, 2900, 2901, 2910 |
Total Applications | 4082 |
Issued Applications | 4006 |
Pending Applications | 1 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6388959
[patent_doc_number] => 20100317718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'MODULATION OF HIF1 BETA EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/846746
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30367
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317718.pdf
[firstpage_image] =>[orig_patent_app_number] => 12846746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/846746 | MODULATION OF HIF1 BETA EXPRESSION | Jul 28, 2010 | Abandoned |
Array
(
[id] => 6383306
[patent_doc_number] => 20100317049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals'
[patent_app_type] => utility
[patent_app_number] => 12/843536
[patent_app_country] => US
[patent_app_date] => 2010-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25990
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317049.pdf
[firstpage_image] =>[orig_patent_app_number] => 12843536
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/843536 | Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals | Jul 25, 2010 | Issued |
Array
(
[id] => 6622742
[patent_doc_number] => 20100311082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals'
[patent_app_type] => utility
[patent_app_number] => 12/843706
[patent_app_country] => US
[patent_app_date] => 2010-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25992
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311082.pdf
[firstpage_image] =>[orig_patent_app_number] => 12843706
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/843706 | Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals | Jul 25, 2010 | Issued |
Array
(
[id] => 8359726
[patent_doc_number] => 20120214862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'MODULATION OF FACTOR 7 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/384327
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36797
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384327
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/384327 | MODULATION OF FACTOR 7 EXPRESSION | Jul 14, 2010 | Abandoned |
Array
(
[id] => 8187560
[patent_doc_number] => 20120116360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'TREATMENT OF NEUROLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/383560
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16208
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20120116360.pdf
[firstpage_image] =>[orig_patent_app_number] => 13383560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383560 | Treatment of neurological disorders | Jul 14, 2010 | Issued |
Array
(
[id] => 10831345
[patent_doc_number] => 08859515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2'
[patent_app_type] => utility
[patent_app_number] => 13/379728
[patent_app_country] => US
[patent_app_date] => 2010-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25535
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/379728 | Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2 | Jun 23, 2010 | Issued |
Array
(
[id] => 10077562
[patent_doc_number] => 09115404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Polynucleotides for medical use'
[patent_app_type] => utility
[patent_app_number] => 13/379084
[patent_app_country] => US
[patent_app_date] => 2010-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 52
[patent_no_of_words] => 24003
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379084
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/379084 | Polynucleotides for medical use | Jun 20, 2010 | Issued |
Array
(
[id] => 8313711
[patent_doc_number] => 20120190728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 13/380021
[patent_app_country] => US
[patent_app_date] => 2010-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24574
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13380021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/380021 | Compositions and methods for modulation of SMN2 splicing in a subject | Jun 16, 2010 | Issued |
Array
(
[id] => 8265974
[patent_doc_number] => 20120165401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'APTAMER FOR CHYMASE, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/377201
[patent_app_country] => US
[patent_app_date] => 2010-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24021
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377201
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/377201 | Aptamer for chymase, and use thereof | Jun 10, 2010 | Issued |
Array
(
[id] => 8976084
[patent_doc_number] => 20130209514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'APTAMER-TARGETED COSTIMULATORY LIGAND APTAMER'
[patent_app_type] => utility
[patent_app_number] => 13/376873
[patent_app_country] => US
[patent_app_date] => 2010-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24612
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/376873 | APTAMER-TARGETED COSTIMULATORY LIGAND APTAMER | Jun 2, 2010 | Abandoned |
Array
(
[id] => 8555197
[patent_doc_number] => 08329670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron'
[patent_app_type] => utility
[patent_app_number] => 12/787552
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12284
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12787552
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/787552 | System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron | May 25, 2010 | Issued |
Array
(
[id] => 8265964
[patent_doc_number] => 20120165391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 13/321013
[patent_app_country] => US
[patent_app_date] => 2010-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6299
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321013 | Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis | May 18, 2010 | Issued |
Array
(
[id] => 6148705
[patent_doc_number] => 20110020300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES'
[patent_app_type] => utility
[patent_app_number] => 12/780813
[patent_app_country] => US
[patent_app_date] => 2010-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27630
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12780813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/780813 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES | May 13, 2010 | Abandoned |
Array
(
[id] => 5993598
[patent_doc_number] => 20110015251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/777767
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 69856
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015251.pdf
[firstpage_image] =>[orig_patent_app_number] => 12777767
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777767 | RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA) | May 10, 2010 | Issued |
Array
(
[id] => 6388949
[patent_doc_number] => 20100317717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/777913
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 68181
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317717.pdf
[firstpage_image] =>[orig_patent_app_number] => 12777913
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777913 | RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA) | May 10, 2010 | Issued |
Array
(
[id] => 6388936
[patent_doc_number] => 20100317716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/777816
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 66119
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317716.pdf
[firstpage_image] =>[orig_patent_app_number] => 12777816
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/777816 | RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA) | May 10, 2010 | Issued |
Array
(
[id] => 7490667
[patent_doc_number] => 20110237643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Identification of a Novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity'
[patent_app_type] => utility
[patent_app_number] => 12/799925
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16277
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237643.pdf
[firstpage_image] =>[orig_patent_app_number] => 12799925
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/799925 | Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity | May 4, 2010 | Issued |
Array
(
[id] => 7774256
[patent_doc_number] => 08119612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'RNAi inhibition of alpha-ENaC expression'
[patent_app_type] => utility
[patent_app_number] => 12/771566
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38409
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119612.pdf
[firstpage_image] =>[orig_patent_app_number] => 12771566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/771566 | RNAi inhibition of alpha-ENaC expression | Apr 29, 2010 | Issued |
Array
(
[id] => 4469963
[patent_doc_number] => 07943592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'RNAi inhibition of alpha-ENaC expression'
[patent_app_type] => utility
[patent_app_number] => 12/771470
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38434
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943592.pdf
[firstpage_image] =>[orig_patent_app_number] => 12771470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/771470 | RNAi inhibition of alpha-ENaC expression | Apr 29, 2010 | Issued |
Array
(
[id] => 6518567
[patent_doc_number] => 20100216971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'RNAi Inhibition of Alpha-ENaC Expression'
[patent_app_type] => utility
[patent_app_number] => 12/771518
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 38403
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12771518
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/771518 | RNAi inhibition of alpha-ENaC expression | Apr 29, 2010 | Issued |